Mitsui, QSimulate, and Quantinuum Launch “QIDO”: A Quantum-Integrated Chemistry Platform Targeting Faster Drug and Materials Discovery

QIDO integrates high-performance quantum chemistry workflows and quantum computing to shorten ‘molecule-to-market’ timelines across the pharmaceutical, energy, and chemical sectors, and beyond

August 19, 2025

Tokyo, Japan, August 19th, 2025 — Mitsui & Co., Ltd. (“Mitsui”), QSimulate, and Quantinuum today announced the launch of a new quantum-integrated chemistry platform, QIDO (Quantum-Integrated Discovery Orchestrator). This platform aims to reduce the time and cost of developing new drugs and materials. QIDO accelerates research and development through high-precision chemical reaction modeling and seamlessly combines the advantages of cutting-edge classical computing and quantum computing.

Built for commercial impact, QIDO streamlines complex quantum-classical hybrid workflows and helps companies make decisions earlier in the development process, contributing to a powerful competitive advantage in innovation. The platform is designed to support research across an array of chemistry-based fields, including advanced materials design, clean energy, and drug development.

Proprietary Technology Supporting QIDO

QIDO seamlessly integrates QSimulate's software “QSP Reaction,” which enables calculations on the scale of thousands of atoms using the highest precision classical quantum chemistry methods and techniques. QIDO also integrates with Quantinuum's “InQuanto" software, which interfaces with state-of-the-art quantum emulators and world-leading Quantinuum Systems hardware. InQuanto™ achieves up to 10 times higher accuracy in simulations of complex molecules and materials compared to open-source software.

  • Makoto Koshida, General Manager, Quantum Innovation Department, Mitsui: “We take a market-needs-based approach, aiming to bridge the gap between providing practical features that help customers solve today's challenges and preparing them for the coming quantum era. This approach enables customers to maximize its benefits from day one when quantum technology comes into its own.”
  • Toru Shiozaki, Ph.D., President & CEO, QSimulate: “Combining best-in-class quantum chemical simulation with deep quantum computing expertise, QIDO gives industrial chemists powerful, intuitive algorithms and tools to tackle complex chemical challenges with speed and accuracy. We are excited about the marriage between years of innovation in quantum chemistry automation and the future of quantum computation.”
  • Dr. Rajeeb Hazra, President & CEO, Quantinuum: “Adding the benefits of chemical accuracy and computational efficiency of quantum-native simulations in applications of chemistry is a key step forward in revolutionizing the economics of discovery in several significant end markets, such as pharmaceuticals and energy. Quantinuum is proud to offer the industry's highest-performing quantum computers and widely used quantum chemistry software to enable this progress.”
QIDO Use Cases and Future Expansion

QIDO is launched together with a high-precision chemical reaction analysis module based on the so-called active space approach. Potential use cases are as follows:

  • Catalysts and enzyme design: Simulating complex electron behavior to inform high-efficiency catalysts and enzymes design for cleaner energy, greener manufacturing, and advanced biocatalysis (useful in drug discovery, food processing, biofuel, etc.).
  • Reaction mechanism elucidation: Enabling deeper understanding of complex chemical reaction pathways, including transient intermediates and excited states, for material stability, performance, and lifetime improvements.
  • Battery efficiency and energy storage: Enhancing battery materials and performance for safer, longer-lasting, and higher-capacity energy storage.
  • Sustainable materials and energy: Advancing energy-efficient materials, improving carbon capture and reuse, and supporting green ammonia and hydrogen production.

QIDO will gradually add new features to accelerate innovation in high-impact use cases, such as battery innovation and drug development. Innovation in these fields through quantum technology will be realized through 'co-creation' with our customers.

Feedback from Industry Leaders

As QIDO's exclusive distributor in Japan and a strategic partner with an eye toward future “co-creation,” Mitsui & Co. is leading domestic sales and distribution, laying the foundation for future global expansion. Prior to the general release of QIDO in the Japanese market, Mitsui & Co. conducted beta testing with three industry-leading companies.

  • JSR Corporation: “The platform provided by QSimulate lowers the barriers to computation by simplifying input, automating error handling, and focusing output on necessary information, making it an integral tool in the daily workflows of synthetic organic chemists at JSR. With this platform now extended to support quantum chemistry calculations on quantum computers via InQuanto, it offers a path to an early quantum advantage.” – Yu-ya Ohnishi, Ph.D., Research Fellow & Deputy Director, R&D Technology & Digital Transformation Center, Materials Informatics Promotion Office
  • Panasonic Holdings Corporation: “This platform provides users with a tool to intuitively perform chemical reaction simulations through a graphical user interface. In the anticipated era of large-scale fault-tolerant quantum computing, materials simulation is regarded as a promising application domain. Integrated with quantum computing, this platform is expected to offer opportunities for early-stage validation in preparation for future breakthroughs.” – Takahiro Ohgoe, Ph.D., Senior Lead Researcher, Green Innovation Center, Green Transformation Division
  • Chugai Pharmaceutical: “This application offers an intuitive interface that combines user-friendly operability with clear, instantly interpretable result visualization—making reaction pathway exploration easier and more efficient than ever. At present, we recognize several technical challenges in applying the system to complex molecular calculations encountered in drug discovery and pharmaceutical research. As these challenges are steadily addressed, we expect this application to play a meaningful role in accelerating and optimizing the synthesis and process development of candidate molecules with complex chemical structures—ultimately contributing to innovation in drug discovery and the advancement of pharmaceutical development.” – Akihiko Arakawa, Ph.D., Data Science Group, Digital Solution Dept., Digital Transformation Unit
Notable Functions of QIDO

QIDO is equipped with various functions to streamline high-precision chemical modeling. This makes quantum chemistry technology, which was previously only available to experts, more accessible for use in industrial settings.

  • Automatically identify reaction coordinates and transition states from specified reactants and products;
  • Map strongly correlated systems to compact Hamiltonians using quantum embedding and automated active space selection techniques;
  • Support customizable active spaces and computational methods to balance accuracy and cost;
  • Provides optimized energy calculations for reactants, products, and transition states using quantum hardware and their emulators;
  • Visualizes quantum circuits and reports the required quantum resources.

For purchases, trial applications, and other details, please visit: https://mitsui-q.com/en/qido/.

About Mitsui & Co., Ltd.

Mitsui & Co. is a global trading and investment company with a presence in more than 60 countries and a diverse business portfolio covering a wide range of industries.

The company identifies, develops, and grows its businesses in partnership with a global network of trusted partners including world leading companies, combining its geographic and cross-industry strengths to create long-term sustainable value for its stakeholders.

Mitsui has set three key strategic initiatives for its current Medium-term Management Plan: supporting industries to grow and evolve with stable supplies of resources and materials, and providing infrastructure; promoting a global transition to low-carbon and renewable energy; and empowering people to lead healthy lives through the delivery of quality healthcare and access to good nutrition.

For more information, please visit: https://www.mitsui.com/jp/en/index.html

About QSimulate

Founded in 2019 and headquartered in Boston, MA, QSimulate is a leader in quantum simulation technology for materials development and life sciences. The company offers a range of products and services designed to leverage the power of quantum mechanics to solve industrial-scale problems like never before.

For more information, please visit: https://qsimulate.com/

About Quantinuum

Quantinuum is the world leader in quantum computing. The company’s quantum systems deliver the highest performance across key industry benchmarks. Quantinuum’s over 550 employees, including 370+ scientists and engineers, across the US, UK, Germany, and Japan, are driving the quantum computing revolution.

For more information, please visit: https://www.quantinuum.com

About Quantinuum

Quantinuum, the world’s largest integrated quantum company, pioneers powerful quantum computers and advanced software solutions. Quantinuum’s technology drives breakthroughs in materials discovery, cybersecurity, and next-gen quantum AI. With over 500 employees, including 370+ scientists and engineers, Quantinuum leads the quantum computing revolution across continents. 

May 8, 2026
Honeywell Announces Quantinuum’s Filing of Registration Statement for Proposed Initial Public Offering

Source: PRNewswire - Honeywell

Charlotte, N.C., May 8th, 2026 — Honeywell (NASDAQ: HON) today announced that Quantinuum, a leading, full-stack quantum computing company, has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of shares of its Class A common stock.

The number of shares to be offered and the price range for the proposed offering have not yet been determined. Quantinuum intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol “QNT.”

J.P. Morgan and Morgan Stanley (in alphabetical order) are acting as joint lead active book-running managers for the proposed offering. Jefferies and Evercore ISI are also acting as active book-running managers.

The proposed offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

The proposed offering will be made available only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com; Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attention: Prospectus Department or by email at prospectus@morganstanley.com; Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, NY 10055, by telephone at 888-474-0200 or by email at ecm.prospectus@evercore.com.

The registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Honeywell

Honeywell is an integrated operating company serving a broad range of industries and geographies around the world. Our business is aligned with three powerful megatrends – automation, the future of aviation and energy transition – underpinned by our Honeywell Accelerator operating system and Honeywell Forge IoT platform. As a trusted partner, we help organizations solve the world's toughest, most complex challenges, providing actionable solutions and innovations through our Aerospace Technologies, Industrial Automation, Building Automation and Energy and Sustainability Solutions business segments that help make the world smarter, safer, as well as more secure and sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity as of December 31, 2025. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, and Singapore.

Contacts:

Media
Stacey Jones
(980) 378-6258
Stacey.Jones@honeywell.com

Investor Relations
Mark Macaluso
(704) 627-6118
Mark.Macaluso@honeywell.com

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All
May 5, 2026
Quantinuum and BMW Group Expand Landmark Quantum Computing Collaboration with New Multi-Year Partnership
  • The companies plan to continue their co-creation partnership to advance future mobility
  • BMW to access the latest generations of Quantinuum systems throughout the partnership
  • Advanced materials science research supports a range of next-generation technologies

Broomfield, Colorado, May 5th, 2026 — Quantinuum and BMW Group have formally expanded their ongoing collaboration into a multi-year partnership with a mission to unlock future mobility by applying quantum computing toward advanced materials science.

Since 2021, Quantinuum and BMW Group have been collaborating on joint research focused on tackling complex challenges in industrial chemistry to support the advancement of next-generation mobility. The collaboration has progressed from foundational algorithm development to advanced simulations of molecular systems, allowing the researchers to unlock insights into catalytic activity, reaction pathways, and material performance in energy-relevant environments.

The companies have now agreed to extend the work, positioning the alliance to become one of the longest-sustained commitments between a commercial enterprise and a quantum computing provider to date.

“Quantinuum is focused on driving commercial adoption of quantum computing through close collaboration with industry leaders on high-impact applications," said Dr. Rajeeb Hazra, President and CEO of Quantinuum. “Our expanded partnership with the BMW Group underscores this focus, and we’re excited to scale the meaningful work we’ve been advancing together.”

Researchers at BMW Group are utilizing Quantinuum's trapped-ion architecture, which provides the high-fidelity operations necessary to accurately simulate molecular systems, particularly electrochemical processes that play a critical role across a range of technologies relevant to sustainable mobility and the design and optimization of fuel cells.

Under the terms of the agreement, BMW Group will leverage successive generations of Quantinuum’s quantum computers. This includes the current Helios system and upcoming generations, Sol (planned for 2027) and Apollo (planned for 2029). This will enable the teams to validate progress at each stage while scaling toward industrially meaningful solutions.

“We have been exploring quantum computing for many years,” said Dr. Martin Tietze, Vice President of New Technologies at BMW Group. “Together with partners such as Quantinuum, we translate advances in quantum hardware into real‑world applications, including materials optimization, supporting the development of future vehicle generations.”

Quantinuum’s progress toward large-scale, fault-tolerant systems helps to ensure that as the hardware reaches milestones in performance, BMW can apply that computational power to catalyst chemistry research, targeting critical oxygen reduction reaction processes at platinum catalysts to potentially lower costs and improve energy efficiency.

The companies broke new ground in 2024, alongside another commercial partner, as the first to simulate catalytic performance using a quantum computer with results published in Nature Partner Journal.

Beyond its technical achievements, the collaboration has evolved into a deeply connected, cross-disciplinary effort, bringing together quantum scientists, chemists, and engineers in a sustained partnership that reflects both the complexity of the challenge and the scale of the ambition.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.[i] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets.

The company has a global workforce of approximately 700 employees, including top scientists and researchers. Over 70% of its technology team hold PhDs or Master's degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, and Singapore.  

For more information, please visit www.quantinuum.com.

[i] As of December 31, 2025.

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All
April 22, 2026
Honeywell Announces Quantinuum’s Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Source: PRNewswire - Honeywell

Charlotte, N.C., April 22nd, 2026 — Honeywell (NASDAQ: HON) today announced that Quantinuum LLC (“Quantinuum” or the “Company”), which is majority owned by Honeywell, confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (the “SEC”) on February 17, 2026, relating to the proposed initial public offering of Quantinuum’s common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC’s review process.

This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the “Securities Act”), and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities, will be made in accordance with the registration requirements of the Securities Act.

Contacts:

Media
Stacey Jones
(980) 378-6258
Stacey.Jones@honeywell.com

Investor Relations
Mark Macaluso
(704) 627-6118
Mark.macaluso@honeywell.com

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All